GLP-1 weight loss drugs creating an opportunity in 2 stocks: analyst
GP1-1 (glucagon-like peptide-1) drugs, originally developed as a treatment for diabetes, are shaking up some sectors. Developments surrounding the drugs, also popularly used for weight loss, have been disrupting anything…